会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Amino-substituted imidazo[1,2-a:3,4-a']diquinolin-15-ium salts
compositions and method of use
    • 氨基取代的咪唑并[1,2-a:3,4-a']二喹啉-15-盐组合物和使用方法
    • US4207320A
    • 1980-06-10
    • US937234
    • 1978-08-28
    • David B. CappsMario M. AngeloTownley P. Culbertson
    • David B. CappsMario M. AngeloTownley P. Culbertson
    • C07D215/04C07D215/18C07D215/26C07D471/14A61K31/535
    • C07D215/04C07D215/18C07D215/26C07D471/14
    • Amino-substituted imidazo[1,2-a:3,4-a']diquinolin-15-ium salts having the formula I: ##STR1## wherein R.sub.1 is hydrogen, lower alkyl, C.sub.4 -C.sub.6 cycloalkyl, di(lower alkyl)amino, 1-azetidinyl, 1-pyrrolidinyl, 1-piperidinyl, methyl-1-pyrrolidinyl, methyl-1-piperidinyl, 4-morpholinyl or 2,2-dimethylhydrazino;R.sub.2 is hydrogen, lower alkyl, lower alkylamino, di(lower alkyl)amino, C.sub.4 -C.sub.6 cycloalkylamino, lower alkoxy(lower alkyl)amino, 1-azetidinyl, 1-pyrrolidinyl, 1-piperidinyl, methyl-1-pyrrolidinyl, methyl-1-piperidinyl, hexahydro-1H-azepin-1-yl, 4-morpholinyl, benzylamino, N-methylbenzylamino or 2-phenylethylamino;R.sub.3 is hydrogen or methyl;X is an anion;with the proviso that at least one of R.sub.1 and R.sub.2 is other than hydrogen, lower alkyl or C.sub.4 -C.sub.6 cycloalkyl; and with the further proviso that when R.sub.2 is dimethylamino, at least one of R.sub.1 and R.sub.3 is other than hydrogen, and intermediates used in the preparation thereof are disclosed. The compounds of the invention are prepared by amination of the corresponding chloro or fluoro-substituted imidazo [1,2-a:3,4-a']diquinolin-15-ium salts; either the halo substituted intermediates or the amino substituted salts may be further treated, typically using ion exchange techniques to obtain a variety of physiologically acceptable amino-substituted [1,2-a:3,4-a']diquinolin-15-ium salts which exhibit antifungal activity.
    • 具有式I的氨基取代的咪唑并[1,2-a:3,4-a']二喹啉-15-盐其中R 1是氢,低级烷基,C 4 -C 6环烷基,二(低级烷基 )氨基,1-氮杂环丁烷基,1-吡咯烷基,1-哌啶基,甲基-1-吡咯烷基,甲基-1-哌啶基,4-吗啉基或2,2-二甲基肼; R2是氢,低级烷基,低级烷基氨基,二(低级烷基)氨基,C4-C6环烷基氨基,低级烷氧基(低级烷基)氨基,1-氮杂环丁烷基,1-吡咯烷基,1-哌啶基,甲基-1-吡咯烷基, 1-哌啶基,六氢-1H-吖庚因-1-基,4-吗啉基,苄基氨基,N-甲基苄基氨基或2-苯乙基氨基; R3是氢或甲基; X是阴离子; 条件是R 1和R 2中的至少一个不是氢,低级烷基或C 4 -C 6环烷基; 并且进一步的条件是当R 2是二甲基氨基时,R 1和R 3中的至少一个不是氢,并且公开了其制备中使用的中间体。 本发明的化合物是通过胺化相应的氯或氟取代的咪唑并[1,2-a:3,4-a']二喹啉-15-盐制备的; 可以进一步处理卤代替中间体或氨基取代的盐,通常使用离子交换技术获得各种生理上可接受的氨基取代的[1,2-a:3,4-a']二喹啉-15-盐 其具有抗真菌活性。